Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease

Yale Journal of Biology and Medicine

Volumn 72, Issue 2-3, 1999, Pages 211-218

  Kuipers, Ernst J ^a   Klinkenberg Knol, Elly C ^a   Meuwissen, Stephan G M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE;

BACTERIAL COLONIZATION; DISEASE ASSOCIATION; ESOPHAGITIS; ESOPHAGUS PH; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; NONHUMAN; REFLUX ESOPHAGITIS; REVIEW; STOMACH PH;

GASTRIC JUICE; GASTRITIS, ATROPHIC; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; PROTON PUMPS; PROTON-TRANSLOCATING ATPASES;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 0033490041     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Verdú, E.F., Armstrong, D., Fraser, R., Viani, F., Idström, J.-P., Cederberg, C., and Blum, A.L. Effect of H. pylori status on intragastric pH during treatment with omeprazole. Gut 36:539-543, 1995.
2. Verd́, E.F., Armstrong, D., Idström, J.-P., Labenz, J., Stolte, M., Dorta, G., Borsch, G., and Blum, A.L. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 37:743-748. 1995.
3. Labenz, J., Tillenburg, B., Peitz, U., Idström, J.-P., Verdú, E.F., Stolte, M., Börsch, G., and Blum, A.L. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725-732, 1996.
4. Labenz, J., Tillenburg, B., Peitz, U., Börsch, G., Idström, J.-P., Verdú, E.F., Stolte, M., and Blum, AL. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am. J. Gastroenterol. 92:576-581, 1997.
5. Labenz, J., Tillenburg, B., Peitz, U., Verdú, E., Stolte, M., Börsch, G., and Blum, A.L. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 41:33-36, 1997.
6. Kuipers, E.J., Uyterlinde, A.M., Peña, A.S., Hazenberg, H.J.A., Bloemena, E., Lindeman, J., Klinkenberg-Knol, E.C., and Meuwissen, S.G.M. Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am. J. Gastroenterology 90:1401-1406, 1995.
7. Schenk, B.E., Kuipers, E.J., Klinkenberg-Knol, E.C., Eskes, S.A., and Meuwissen, S.G.M. Helicobacter pylori, GERD and the efficacy of omeprazole therapy. Gastroenterology 94:884-887, 1999.
8. Klinkenberg-Knol, E.C, for the International Long-term Omeprazole Study Group: eleven years experience of continuous maintenance treatment with omeprazole in GERD-patients. Gastroenterology 118:2000. (In press).
9. Peters, F.T.M., Kuipers, E.J., Ganesh, S., Sluiter, W.J., Klinkenberg-Knol, E.C., Lamers, C.B.H.W., and Kleibeuker, J.H. Helicobacter pylori and esophageal acid exposure in GERD. Aliment. Pharmacol. Ther. 13:921-926, 1999.
10. Logan, R.P.H., Walker, M.M., Msiewicz, J.J., Gummett, P.A., Karim, Q.N., and Baron, J.H. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36:12-16, 1995.
11. Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., Havu, N., Festen, H.P.M., Liedman, B., Lamers, C.B.H.W., Jansen, J.B.M.J., Dalenbäck, J., Snel, P., Nelis, G.F., and Meuwissen, S.G.M. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med. 334:1018-1022, 1996.
12. Stolte, M., Bethke, B., Blum, A.L., Sulser, E., and Stadelmann, O. Antacid treatment has a deleterious effect on the severity and activity of gastritis of the corpus mucosa. Ir. J. Med. Sci. 161(suppl 10):6, 1992.
13. Berstad, A.E., Hatlebakk, J.G., Maartmann-Moe, H., Berstad, A., and Brandtzaeg, P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 41:740-747, 1997.
14. Kuipers, E.J., Lee, A., Klinkenberg-Knol, E.C., and Meuwissen, S.G.M. Review article: The development of atrophic gastritis -Helicobacter pylori and the effects of acid suppressive therapy. Aliment. Pharmacol. Therap. 9:331-340, 1995.
15. Dixon, M.F., Genta, R.M., Yardley, J.H., and Correa, P. Classification and grading of gastritis. The up-dated Sydney system. Am. J. Surg. Pathol. 20:1161-1181, 1996.
16. Correa, P., Haenszel, W., Cuello, C., Zavala, D., Fontham, E., Zarama, G., Tannenbaum, S., Collazos, T., and Ruiz, B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 50:4737-4740, 1990.
17. Kuipers, E.J., Uyterlinde, A.M., Peña, A.S., Roosendaal, R., Pals, G., Nelis, G.F., Festen, H.P.M., and Meuwissen, S.G.M. Long term sequelae of Helicobacter pylori gastritis. Lancet 345:1525-1528, 1995.
18. Villako, K., Kekki, M., Maaroos, H.I., Sipponen, P., Tammur, R., Tamm, A., and Keevallik, R. A 12-year follow-up study of chronic gastritis and Helicobacter pylori in a population-based random sample. Scand. J. Gastroenterol. 30:964-967, 1995.
19. Maaroos, H.I., Salupere, V., Uibo, R., Kekki, M., and Sipponen, P. Seven-year follow-up study of chronic gastritis in gastric ulcer patients. Scand. J. Gastroenterol. 20:198-204, 1985.
20. Jönsson, K.Å., Ström, M., Bodemar, G., and Norrby, K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapylofic ulcer disease. Scand. J. Gastroenterol. 23:433-441, 1988.
21. Peetsalu, A., Maaroos, H.I., Sipponen, P., and Peetsalu, M. Long-term effect of vagotomy on gastric mucosa and Helicobacter pylori in duodenal ulcer patients. Scand J Gastroenterol 26(suppl 186):77-83, 1991.
22. Solcia, E., Fiocca, R., Havu, N., Dalväg, A., and Carlsson, R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion 51(suppl 1):82-92, 1992.
23. Lamberts, R., Creutzfeldt, W., Strüber, H.G., Brunner, G., and Solcia, E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:1356-1370, 1993.
24. Filipe, M.I., Muñoz, N., Matko, I., Kato, I., Pompe-Kim, V., Jutersek, A., Teuchmann, S., Benz, M., and Prijon, T. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int. J. Cancer 57:324-329, 1994.
25. Ectors, N. and Dixon, M.F. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 10:1271-1277, 1986.
26. International Agency for Research on Cancer. WHO - Cancer in the Five Continents. Lyon: 1989.
27. Lundell, L., Miettinen, P., Myrvold, H.E., Pedersen, S.A., Thor, K., Andersson, A., Hattlebakk, J., Havu, N., Janatuinen, E., Levander, K., Liedman, B., and Nystrom, P. Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow-up. Gastroenterology 112:A771, 1997.
28. Eissele, R., Brunner, G., Simon, B., Solcia, E., and Arnold, R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil-cell hyperplasia. Gastroenterology 112:707-17, 1997.